These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1503420)

  • 1. Activity of CuDIPS against mammary cancer in C3H HeNCR mice.
    Crispens CG; Sorenson JR
    Anticancer Res; 1992; 12(4):1271-3. PubMed ID: 1503420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of glutathione in the antitumor effect of a copper-containing synthetic superoxide dismutase in mice.
    Oberley LW; Rogers KL; Schutt L; Oberley TD; Leuthauser SW; Sorenson JR
    J Natl Cancer Inst; 1983 Nov; 71(5):1089-94. PubMed ID: 6580486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the anticancer activity of CuDIPS in SJL/J mice.
    Crispens CG; Sorenson JR
    Anticancer Res; 1988; 8(1):77-9. PubMed ID: 3358641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with CuDIPS, Tween 80 and cyclophosphamide: effects on survival and tumor incidence in SJL/J mice.
    Crispens CG; Sorenson JR
    In Vivo; 1990; 4(5):321-3. PubMed ID: 2133105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of combinations of CuDIPS, Tween 80 and cyclophosphamide as therapy for reticulum cell sarcoma in SJL/J mice.
    Crispens CG; Sorenson JR
    Anticancer Res; 1989; 9(2):357-9. PubMed ID: 2665634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of CuDIPS in mice.
    Crispens CG; Chidambaram MV; Torregrosa D; Salari H; Bond K; Kearns GL; Gray RA; Epperson CE; Baker ML; Griffey B
    Anticancer Res; 1989; 9(4):1213-6. PubMed ID: 2817805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice.
    Kossoy G; Anisimov VN; Ben-Hur H; Kossoy N; Zusman I
    In Vivo; 2006; 20(2):253-7. PubMed ID: 16634527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
    Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
    Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
    Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of phorbol ester stimulated interleukin 2 production by copper(II) complexes.
    Harrison JR; Rillema DP; Ham JH; Sando JJ
    Cancer Res; 1986 Nov; 46(11):5571-5. PubMed ID: 3019529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of platinum(II) complexes with histamine and radioiodinated histamine in a transplantable murine adenocarcinoma model.
    Garnuszek P; Karczmarczyk U; Maurin M
    Nucl Med Biol; 2008 Jul; 35(5):605-13. PubMed ID: 18589305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the mechanism of action of complex copper (II) compounds with alpha-amino acids].
    Treshchalina EM; Matveĭchuk NV; Gudratov NO; Potapova GI
    Biull Eksp Biol Med; 1985 Jan; 99(1):86-8. PubMed ID: 4038465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
    Lawson KA; Anderson K; Snyder RM; Simmons-Menchaca M; Atkinson J; Sun LZ; Bandyopadhyay A; Knight V; Gilbert BE; Sanders BG; Kline K
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):421-31. PubMed ID: 15197487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
    Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC
    Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics in antitumor effects of organic silicon related compounds].
    Fukushima K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2173-81. PubMed ID: 2544147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of the antitumor effect of Z-100 in the treatment of MM 46 tumor transplanted in C3H/He mice. 1. Effect of long-term administration of Z-100].
    Ogawa Y; Inomata T; Yoshida S; Maeda T; Seguchi H
    Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2551-8. PubMed ID: 3209924
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
    Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic exposure of cancer-prone mice to low-level 2450 MHz radiofrequency radiation.
    Frei MR; Berger RE; Dusch SJ; Guel V; Jauchem JR; Merritt JH; Stedham MA
    Bioelectromagnetics; 1998; 19(1):20-31. PubMed ID: 9453703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.